The future of prosthetics is osseointegrated implants

NEW LEG PROSTHESIS GAINS FDA APPROVAL (Orthopedics this Week) Company website The conventional treatment for an amputation above the knee is a specially fitted cup-like shell called a socket. It fits over the remaining portion of the patients’ leg and helps secure the device to the leg. If patients do not have a long enough residual limb to properly fit socket prosthesis or have other conditions, such as scarring, pain, recurrent skin infections, or fluctuations in the shape of the residual limb they are just out of luck. To remedy that situation the FDA has authorized the first prosthesis to be marketed in the U.S. for patients who cannot use the conventional socket prosthesis. The device is called the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA). It uses fixtures and screws that are implanted into the patient’s remaining thigh bone to connect an external limb. According to the FDA press release, the OPRA device is installed with two surgical procedures. In the first procedure, a cylinder-shaped fixture is implanted into the central canal of the remaining thigh bone. Approximately six months later, after tissue has grown to anchor the fixture and the skin tis...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top